OTHER · Unmapped registry intervention
NeuroQuant
Find medicine records ·
Find other trials using this name
Clinical trial
Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM
NCT05684016
Study summary
ClinicalTrials.govAssessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Automated Neuropsychological Assessment Matrices
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
EDSS
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Physical Examination
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Multiple Sclerosis, Relapsing-Remittingunresolved
Interventions
Sponsors & collaborators
George Washington Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05684016 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.